Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Post-Approval Drug Issues
Post-Approval Drug Issues
by marina-yarberry
FDLI-Introduction to Drug Law Regulation. By: . ...
Regulatory Issues Introduction to the Regulatory Approval Process; Overview of the FDA
Regulatory Issues Introduction to the Regulatory Approval Process; Overview of the FDA
by liane-varnes
Investigational New Drug Application (IND); Summa...
Incentives for Drug Approval - How & Why to Use Them
Incentives for Drug Approval - How & Why to Use Them
by ellena-manuel
Aquaculture Drug Workshop. Bozeman, Montana. July...
Drug Approval and Regulation
Drug Approval and Regulation
by sherrill-nordquist
John Paul Joson MSN CNS. 1. Objectives. Role of t...
Orphan Drug Global Incentives & Regulatory Framework
Orphan Drug Global Incentives & Regulatory Framework
by pasty-toler
Marlene E. Haffner, MD, MPH. CEO, Haffner Associ...
Incentives for Drug Approval - How & Why to Use Them
Incentives for Drug Approval - How & Why to Use Them
by lindy-dunigan
Aquaculture Drug Workshop. Bozeman, Montana. July...
Strategies for generic drug
Strategies for generic drug
by kittie-lecroy
development . Dr. S. Padmaja, Managing Partner, i...
CAN DRUG IMPORTATION ADDRESS HIGH GENERIC DRUG PRICES Thomas J Bolly
CAN DRUG IMPORTATION ADDRESS HIGH GENERIC DRUG PRICES Thomas J Bolly
by oryan
patent brand-name medicines. Low-cost generic drug...
VAMENABS Effective Tier Formulary Select Drug List Pending Regulatory Approval B VAMENAHK VA Select Drug List SH Anthem Blue Cross and Blue Shield Select Drug List Your prescription drug benet
VAMENABS Effective Tier Formulary Select Drug List Pending Regulatory Approval B VAMENAHK VA Select Drug List SH Anthem Blue Cross and Blue Shield Select Drug List Your prescription drug benet
by luanne-stotts
You can often 64257nd more savings when your doct...
The Rare Disease Treatment Approval Process:
The Rare Disease Treatment Approval Process:
by lily
Balancing Gold Standard Evidence with Patient-Cent...
Pharma Workshop IV
Pharma Workshop IV
by conchita-marotz
Patent Linkage in the USA. Lawrence T. Welch. El...
The DMO:
The DMO:
by trish-goza
Improving the Quality, Quickness. and Quantity of...
ANDA REGULATORY APPROVAL PROCESS
ANDA REGULATORY APPROVAL PROCESS
by faustina-dinatale
Abbreviated new drug application (ANDA) . These a...
The FDA Approval Process for
The FDA Approval Process for
by unita
New Devices. Roxana Mehran, MD, MSCAI, FACC, FAHA,...
Dosage Form Design Lecture 1
Dosage Form Design Lecture 1
by rosemary
17/2/2019. Dr. . Athmar. . Dhahir. Habeeb. PhD i...
Promising Pathway Act With a Focus on Glioblastoma Multiforme (GBM) and Diffuse Midline Glioma (DMG
Promising Pathway Act With a Focus on Glioblastoma Multiforme (GBM) and Diffuse Midline Glioma (DMG
by hudson
Al Musella, DPM. President. Musella Foundation For...
Introduction to Pharmacology: Drug Regulation and Approval
Introduction to Pharmacology: Drug Regulation and Approval
by pamella-moone
Chapter 1. John Paul Joson MSN CNS. OBJECTIVES. W...
OFF-LABEL DRUG USE: ITS ETHICAL IMPLICATIONS &
OFF-LABEL DRUG USE: ITS ETHICAL IMPLICATIONS &
by jane-oiler
NEED FOR FURTHER RESEARCH. PATRICIA M KHU, MD,MS....
Abbreviated New drug Application (ANDA)
Abbreviated New drug Application (ANDA)
by sherrill-nordquist
By. : Mrs. . Reenoo. . Jauhari. Asst. Prof.. Dep...
OFF-LABEL DRUG USE: ITS ETHICAL IMPLICATIONS &
OFF-LABEL DRUG USE: ITS ETHICAL IMPLICATIONS &
by stefany-barnette
NEED FOR FURTHER RESEARCH. PATRICIA M KHU, MD,MS....
1 Meg Oeller, DVM Office of Minor Use & Minor Species Animal Drug Development
1 Meg Oeller, DVM Office of Minor Use & Minor Species Animal Drug Development
by phoebe-click
FDA/CVM Rockville, MD. Summer, 2012. An Overview ...
Drug Development Stages IRB continuing education
Drug Development Stages IRB continuing education
by madison
Walter K. Kraft. Fall 2018. Sage words from an . o...
Drug-eluting coronary stent market overview
Drug-eluting coronary stent market overview
by tracy
Zach Eddy, Category Advisor. 2. What are drug-elut...
Mrs. Brandi Robinson Office of New Animal Drug Evaluation
Mrs. Brandi Robinson Office of New Animal Drug Evaluation
by calandra-battersby
Center for Veterinary Medicine. Regulating Anima...
Thierry Le Chevalier, MD
Thierry Le Chevalier, MD
by yoshiko-marsland
How . d. o International Regulatory Groups View C...
Thierry Le Chevalier, MD
Thierry Le Chevalier, MD
by aaron
How . d. o . International Regulatory Groups View...
Working with the IRB: why, when, who, how, What,
Working with the IRB: why, when, who, how, What,
by ellena-manuel
& Where. Kevin L. Nellis, MS, CIP. Executive ...
White Paper S
White Paper S
by harmony
trengthening the Accelerated Approval Pathway1STRE...
Emergency use of a test article / treatment use of investigational drugs
Emergency use of a test article / treatment use of investigational drugs
by thomas
Emergency use is different than. Expanded Access (...
Lessons Learned from Sovaldi -
Lessons Learned from Sovaldi -
by tawny-fly
The Future is NOW in Specialty Pharmacy. August, ...
FDA’s Access Mechanisms
FDA’s Access Mechanisms
by roxanne
When They Work – When They Don’t . And Why. St...
Pharmaceuticals
Pharmaceuticals
by calandra-battersby
HSPM J712. 11/10/2010. What is the real product o...
The Patented Medicines (Notice of Compliance) Regulations
The Patented Medicines (Notice of Compliance) Regulations
by olivia-moreira
Don Cameron. Bereskin & Parr LLP. April 17, 2...
1 Meg Oeller, DVM
1 Meg Oeller, DVM
by alexa-scheidler
Office of Minor Use & Minor Species Animal Dr...
Acquired Resistance Patient Forum
Acquired Resistance Patient Forum
by briana-ranney
September 6, 2014 | Boston. In ALK, ROS1 & EG...
THE NAME GAME Lisa M. Tittemore,
THE NAME GAME Lisa M. Tittemore,
by pasty-toler
Esq.. Sunstein Kann Murphy & Timbers LLP. Ju...
Regulatory Toxicology Presentation
Regulatory Toxicology Presentation
by marina-yarberry
Overview. Overview. . of. . the. . Food. . an...
The Physicians Proposal for a National Pharmaceutical Program
The Physicians Proposal for a National Pharmaceutical Program
by lindy-dunigan
PNHP Annual Meeting 2016. Adam Gaffney, MD. David...
Clinical Investigator Training Course
Clinical Investigator Training Course
by luanne-stotts
Issues in Clinical Trial Design for Rare Diseases...
Future Pharmaceutical Trends
Future Pharmaceutical Trends
by pamella-moone
Future Pharmaceutical Trends - Patent & Pipe...